ArticleEuropean journal of preventive cardiology2021

Proprotein convertase subtilisin/kexin type 9 inhibitors in half of all patients after acute coronary syndrome? Maybe not.

Yvo SmuldersPubMed ↗Publisher ↗

No numbers read from the abstract.